Judge Orders Florida Stem Cell Clinic To Stop Producing Stem Cell Treatments
Federal court rules that US Stem Cell in Florida must halt injections of stem cell products until the company obtains licenses from the US FDA to market them and demonstrates compliance with drug GMP requirements. This action follows numerous adverse events associated with these product; several patients experienced vision loss after eye injections.
You may also be interested in...
Pew Charitable Trusts calls for FDA to take more aggressive enforcement against regenerative medicine products, but the outcome of a bench trial involving two stem cell clinics may limit what the agency can do.
Court denies FDA request for summary judgement in suit against two clinics treating patients with cells derived from their fat tissue; trial to determine whether exception to FDA regulation applies.
Court overrides stem cell clinic’s dismissal of drug GMPs, the US FDA upbraids drug makers for quality unit shortfalls, and a variety of snafus trigger drug recalls.